NEW YORK (GenomeWeb News) – GE Healthcare has signed agreements with two separate firms intended to expand its offerings in the high-content cell screening field, the firm announced today.
 
The first pact is with Process Analysis and Automation, under which PAA will provide automated hardware and software for GE Healthcare’s IN Cell Analyzer and LEADseeker platforms.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.